Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?. Issue 8 (29th March 2021)

• Record Type: Journal Article
• Authors: Ravishankar, Ramanish; Turkistani, Leenah; Elghoneimy, Yasser; Manoly, Imthiaz
• Is Part Of: Clinical case reports. Volume 9:Issue 8(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-03-29
• Subjects: cardiopulmonary bypass -- cardiothoracic surgery -- hemotology -- sickle cell disease; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.4085
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes. Abstract : Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.